Skandinaviska Enskilda Banken (SEB)’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,000
Closed -$294K 751
2025
Q3
$294K Buy
+20,000
New +$204K ﹤0.01% 691
2024
Q1
Sell
-39,400
Closed -$440K 841
2023
Q4
$440K Sell
39,400
-12,000
-23% -$110K ﹤0.01% 785
2023
Q3
$794K Buy
51,400
+24,800
+93% +$416K 0.01% 713
2023
Q2
$504K Buy
+26,600
New +$467K ﹤0.01% 790

Other funds holding ETNB

Skandinaviska Enskilda Banken (SEB)'s ETNB Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of 89bio (ETNB) in Q4 2025, closing a stake of 20,000 shares — an estimated $294K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ETNB in Q2 2023 and held it in 4 quarters. The position peaked at $794K in Q3 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 20,000 89bio shares in Q4 2025, an estimated $294K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in 89bio in Q2 2023 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s 89bio position peaked at $794K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.